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Permanence of the information given during
oncogenetic counseling to persons at familial
risk of breast/ovarian and/or colon cancer
Fabrice Kwiatkowski*,1, Pascal Dessenne1, Claire Laquet1, Marie-Franc ¸oise Petit1 and Yves-Jean Bignon1
How long counselees retain the information given during their genetic consultation is of major importance. To address this issue,
we conducted a survey among the 3500 families that have been offered genetic counseling at our Center since 1988. In August
2007, we mailed a questionnaire to a representative subset of 579 persons belonging to breast/ovarian or colon cancer families
seen in the last 10 years, either carrying an identiﬁed mutation or not. Targeted topics included the meaning of hereditary
predisposition, the medical prevention related to the familial risk, the steps to undertake for a new family member to enter the
genetic testing program and general knowledge of hereditary predisposition to cancer. A total of 91 randomized non-respondents
were sent a second, more inciting letter, in order to assess any non-response bias. Overall, 337 questionnaires were collected:
response rate was 58%. Standardized average knowledge was 7.28±1.52 of 10. Scores were lowest concerning medical
prevention. The level of knowledge decreased with age (Po10 6), but increased with educational level (Po10 5) and mutation
status (P¼0.01). Surprisingly, no erosion of patients’ knowledge over the time was observed (P¼0.41). Among persons at
hereditary risk of colon cancer, the level of knowledge tended to improve with time, in contrast to the breast/ovarian group
(P¼0.017). Among persons with a familial risk of breast/ovarian or colon cancer, a renewal of oncogenetic counseling does not
seem necessary to maintain the level of speciﬁc knowledge. Measures to help patients follow their medical prevention, as
organizing or checking their medical examinations, seem indicated.
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INTRODUCTION
Oncogenetic counseling for predictive genetic testing has existed for
more than 20 years in France, and the comprehensive cancer hospital
Jean Perrin in Clermont-Ferrand has been a pioneer in that domain,
beginning this activity in 1988. Since then, more than 3500 families
have been accrued, mainly at risk of breast, ovarian and colon cancer,
and about 100000 persons belonging to these families have been
registered in our database. Measures of the psychological impact of
predictive genetic counseling have been of interest for many years.1
Other more recent reviews conﬁrm the relatively mild emotional
consequences of predictive genetic testing and better knowledge of
the recipient.2,3 The follow-up period of these studies was very short,
however, often less than 2 years, which limits the range of conclusions
to be drawn. The importance of the consultation content has been
explored.4 It has been shown that the satisfaction of the recipients was
mainly dependent on the quality and quantity of information given by
the consultant, and that the evaluation of coping strategies of
recipients was essential to minimize emotional consequences. As
recipients are expected to transmit their informations to relatives,
these emotional consequences are not limited to the counseling itself
but they may last long after. To report a mutation discovery has very
often negative impacts on familial relationships and on the whole
communication within the familial circle.5–7 Moreover, information
of other members of the family may be impaired by insufﬁcient
knowledge of transmitters8 and/or a wrong understanding of the
hereditary cancer risk.9
The evolution of the recipients’ knowledge is thus very important.
It may inﬂuence two major points:
  The recipient’s compliance with the recommendations given, and
therefore the quality of his/her medical surveillance.
  The extension of medical management to relatives (recruitment of
new family members), insofar as he can communicate correct
information and persuade them to request genetic testing and
counseling.
The persistence of recipients’ genetic knowledge has been addressed in
very few studies: most of them concerned the short-term recall of the
delivered information (1–6 months after consulting).10–12 In two
others,13,14 the delay was longer (1–5 years after consultation) and
targeted women at breast/ovarian cancer risk, but studied information
was limited to individual and offspring cancer risk, heredity likelihood
and/or early detection schemes: the persistance of information was
found to be poor and depended on the mutational status of recipients.
The survey of Somer et al15 was the oldest one (1988): it tested a large
sample of counselees (N¼791) but the matter of interest was the
consequences of the diagnosis on attitudes toward reproduction,
prenatal study and abortion, and did not focus on genetic mutations
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www.nature.com/ejhgrelated to long-term cancer predispositions. Concerning the retention of
information, these authors concluded that most of the essential facts were
correctly recalled and no signiﬁcant decrease in time could be noticed.
As adequate oncogenetic knowledge is mainly obtained during one
or two consultations with specialists, we suspected as some of these
authors that it would likely fade away in time, and thus questioned the
necessity to renew the recipients’ genetic information through
periodic consultations. The long follow-up of numerous consulting
families in our hospital, as their members had not consulted for years,
enabled us to evaluate the permanence of their knowledge. To obtain
information about whether and how recipients’ knowledge was fading,
and at what frequency a renewal of their information might be useful,
we conducted a survey among a representative sample of almost 600
individuals belonging to families at risk of breast, ovarian and/or
colon cancer.
SUBJECTS AND METHODS
Genetic counseling at our center involves a geneticist, a physician, a genetic
counselor (nurse), a psychologist and a secretarial service. An engineer is
responsible for the computer management of medical data. After an initial
contact by telephone patients are asked to describe their genealogical tree,
indicating cancers and other possible hereditary diseases. In an initial
consultation, patients present themselves and their pedigree to the genetic
counselor, who helps the patients complete their genealogical tree and informs
them about hereditary cancer risk and the genetic testing process. The patients
then meet the geneticist, who evaluates the hereditary risk. If genetic testing is
indicated, the patients are provided with further medical information and a
ﬁrst-blood sample is taken (a second one is required later if a mutation is
found). An information booklet concerning the type of familial risk is offered,
and a letter is sent to their general practitioner (or other physician if they wish)
to inform them about the onset of genetic testing.
Once the analysis is completed, the patient returns for a second pair of
consultation, with the genetic counselor and then with the geneticist or the
physician. The genetic counselor updates the pedigree, if needed, with the
patients and evaluates their global knowledge and their capacity to cope with
the announcement of the result. Two types of consultation are possible with the
geneticist/physician:
  An individual mode where the result is given to the person alone.
  A familial mode where the results of the genetic analysis (positive or
negative) are given to several members of a family, but without telling who
is a carrier. This type of consultation is indicated when the whole result is
negative or when the carrier of the found mutation is not present. Actually,
this latter mode is less and less used as it has shown some limits.
Personal cancer risk is explained and recommendations are given concerning
suitable medical supervision and the necessity to encourage relatives to ask for
genetic testing in order to be beneﬁted from effective screening and prevention.
A ﬁnal letter is then addressed to the patient(s) and his/her designated
doctor(s). All along the research, the recipients are informed that they can
always ask for a consultation with the psychologist.
Database of familial information
An updated version of SEM software16 was used to extract a representative
sample of probands and relatives from our genetic consultation database. This
version stores standard information, including gender, birth date, address,
marital status and also medical data such as date of past consultations, type of
mutation (if any), cancer (if any) location and age at diagnosis, disease status
and date of death.
Development of the questionnaire
A committee of experts (geneticists, physicians, psychologists, nurses and
statistician) was designated to elaborate a questionnaire that could answer to
deﬁned questions. The face and content validity was assessed by a group of
oncologists, radiotherapists, surgeons, nurses, health supervisors, secretaries,
biologists and patients. Questions were either direct (addressed to the respon-
dent) or indirect (general purpose, use of the third person) and sometimes
partially redundant to facilitate cross-controls.
Questions were grouped into several sections:
  Marital status, children, activity, educational level and cancer history
  Date of last genetic counseling session
  Present compliance with medical recommendations
  General knowledge of the meaning of hereditary predisposition to cancer
  Necessary steps for a new family member to obtain genetic testing
  General knowledge about screening, genetic mutations and their
consequences
  How transmission of genetic information is done or inhibited within the
family
  Difﬁculties in putting recommendations into practice
  Remarks on the breast/ovarian cancer information booklet
In all, 10 questions concerned the section ‘current compliance with medical
recommendations’, and presented a series of possible examinations (mammo-
graphy, MRI, clinic, ultrasound, trans-vaginal ultrasound, cervical smear,
aspirative smear, colonoscopy, occult bleeding, blood markers dosage, etc)
for which the subject was asked to specify the recommended frequency in
relationship with his/her cancer risk. Available answers ranged from 6 months
to never, including 6, 12, 18 and 24 months. Correctness scoring was adjusted
according to the history of cancer of each subject. Answers were counted as
correct if they applied to the subject.
The fourth section tested knowledge of the meaning of hereditary predis-
position. Seven questions proposed degrees of agreement with various proposi-
tions, including
  a supplementary risk of cancer for yourself, your family;
  predisposition to a certain kind of cancer for yourself, your family;
  a diagnosis of cancer;
  a vulnerability to environmental factors;
  ar i s ko fi n f e c t i o n .
The last three topics were considered false, although some could argue whether
mutations associated with cancer represent a possible weakness to environ-
mental threats.
The ﬁfth section, of 11 questions, grouped propositions concerning the
necessary steps for someone to start a personal genetic inquiry. One or two
consultations with a geneticist were the ﬁrst questions. Different types of
biological samples were then proposed: saliva, urine, skin, blood (one or two
samples), hair, semen (for men) and lumbar puncture. A scan or RMI was the
last item. According to our actual genetic testing process, good answers were
two consultations and two blood samples, as a mutation discovery must be
certiﬁed by identical results on two different blood samples obtained at two
different times. But one consultation and a single blood sample were also rated
correct since years ago, this was the recommendation.
The sixth chapter entitled ‘General knowledge about screening, genetic
mutations and their consequences’, comprised 24 proposals, all presented with
a Likert scale enabling to quote the degree of agreement. They were labeled as
possibly true or false sentences, as for example:
  Some cancers are hereditary.
  If one has a familial predisposition, it means he would necessarily have a
cancer.
  A genetic mutation transmits itself more often between a parent and
children of the same sex.
  The cancer is not hereditary, but the predisposition is.
  Obtaining my personal genetic test can increase my cancer risk.
Further sections are not treated in this report.
Inclusion and response diagram
After approval by the local ethics committee, the anonymous questionnaire was
mailed to a representative subset of 579 probands and relatives from our
Does given genetic information fade with time?
F Kwiatkowski et al
142
European Journal of Human Geneticsdatabase, with a letter to introduce the survey signed by the geneticist. In order
to limit heterogeneity, only breast/ovarian and colon cancer risks were targeted.
The pre-selection search of the database identiﬁed for living persons
registered in families at risk of breast, ovarian and/or colon cancer, with a
genetic counseling consultation in the last 10 years, older than 18 years and
with a known address. A randomization was performed within the non-
mutated breast/ovarian group in order to reduce its size, but in other groups
we kept all the subjects in order not to reduce analysis power. So, no exclusions
were made in mutation-carrier groups, as these categories were smaller
(Figure 1). To assess possible non-response bias, a second mailing was sent
to one third of a randomized subset of non-respondents.
Survey design and statistics
The number of persons contacted was calculated to provide±5% precision in
the results (range of the 95% conﬁdence interval), which required 400
responses. A ﬁnal response rate of 58% was achieved with 337 answered mails
over 579, thus 63 fewer than the 400 expected. The accuracy of the main results
was therefore±5.3%, which remained acceptable.
Answers to the survey questions are treated in a quantitative or qualitative
manner as appropriate. Most were scored on four-level Likert scales (from total
disagreement to complete agreement) in order to force respondents to choose
one side or the other (with a ﬁve-level scale, many persons select the median
class). Likert scale results were transformed into scores and conﬁdence intervals
calculated, using 0 for total disagreement, 1 for mild disagreement, 2 for mild
agreement and 3 for maximal agreement.
When answers reﬂected a state of knowledge from other sources, or
when they were compared with information given during oncogenetic counsel-
ing, they generally were either right or wrong, making it possible to group
questions of a section and compute an average ‘grade’ over 10 that measured
the correctness of the subjects’ answers. The larger the gap was between
this grade and the optimum of 10, the less knowledge the subject retained
for the topic. Sections containing medical or practical information were treated
in this way.
For statistical testing, standard repartition parameters (numbers, means,
medians, standard deviations and ranges) were calculated. Tests used to study
the link between pairs of variables consisted of w2, one-way ANOVA or
Kruskal–Wallis H test (depending on normality of distributions and/or
difference of variances) and Pearson’s correlation coefﬁcient or Spearman’s
rank tests. Intra-subject comparisons were performed using paired tests.
Standard P-values less than 0.05 were used as the threshold for signiﬁcance.
Statistical tests were performed using the SEM software.16
RESULTS
Population characteristics
Surveyed subjects all resided in the region surrounding the Center
where genetic counseling was performed, with 54% living in the
department and 46% in neighboring departments. The response rate
was not related to distance from the Center (P¼0.83).
In all, 86% of the respondents were female (Table 1) as expected, as
the main indication for genetic counseling was breast/ovarian cancer
risk and analysis of the BRCA1 and BRCA2 genes.
A total of 56% of respondents had a personal history of cancer, as
this was the main reason for seeking genetic consultation: 83% were
breast cancers, 8% colon, 4% ovarian, and endometrial, thyroid, skin,
prostate, stomach, bladder, lymphoma and lung at less than 2%. Half
(166/337) occurred in families with a mutation, though 44 of these did
not carry the familial mutation.
Median delay after genetic counseling was 1.5 years. The yearly
distribution of this delay is shown in Figure 2.
For 40% of subjects, genetic counseling occurred the year before the
survey. Only 53 questionnaires (16%) were obtained with more than
3 years follow-up. Because of randomization, this distribution reﬂected
our global population accrual. But it could have been relevant to try to
balance the older patients’ classes with a different sampling method.
Bias analysis
Although the response rate did not signiﬁcantly differ between distant
and recent consultations (P¼0.12), the answer rate was 11% lower
when the delay after counseling was over 3 years (52 versus 41%). Also,
older persons, males, persons with no history of cancer and/or at risk
of cancers other than breast/ovary did not answer as frequently, but
none of these tendencies were signiﬁcant (Table 2).
Comparison of the response rate with educational level was not
available, as we did not have this information for non-respondents.
Comparison between respondents to the ﬁrst and second mailings
gave slightly different results. Respondents to the second mailing were
a bit older (+5.3 years, P¼0.044), but their educational level and
employment status were similar (P¼0.70 and 0.86, respectively). A
profession in the medical domain did not change the response rate
(P¼0.35). One difference appeared concerning the question ‘did the
genetic counseling change your perception of your cancer risk’: among
ﬁrst responders, 53% said yes, versus 72% of second responders
(P¼0.027). Other criteria added nothing to previous comparisons
between respondents and non-respondents.
Measures of subjects’ knowledge
Figure 3 shows the scores obtained from all subjects.
Pre-selection
942 persons extracted from database
Randomization in the 1st group to reduce its size
- non mutated breast/ovarian :
- mutated breast/ovarian :
- non mutated colon :
- mutated colon :
questionnaire mailed to 579 subjects
Initial response rate : 289 / 579 = 50 %
- non mutated breast/ovarian :
- mutated breast/ovarian :
- non mutated colon :
- mutated colon :
Second mailing to 91 subjects to control for non-response
bias 48 responses = 53 %
- non mutated breast/ovarian :
- mutated breast/ovarian :
- non mutated colon :
- mutated colon :
Final rates : 337 responses / 579 subjects = 58 %
- non mutated breast/ovarian :
- mutated breast/ovarian :
- non mutated colon :
- mutated colon :
307 / 670
162 / 162
59 / 59
51 / 51
165 / 307
78 / 162
20 / 59
26 / 51
22 / 35
15 / 30
8 / 15
3 / 11
(60%)
(53%)
(49%)
(53%)
183 / 307
86 / 162
29 / 59
27 / 51
Figure 1 Flowchart of survey accrual. Numbers indicate responses/
questionnaires sent.
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edge of medical intervention scored lowest, at 6.85. The mean value of
t h ef o u rs c o r e sw a s7 . 2 8 ±1.52 (standard deviation).
This global level of knowledge was higher when among mutation
carriers (P¼0.021), and those belonging to a mutated family
(P¼0.014), among subjects still working (P¼0.00015) and if their
profession was related to the medical domain (P¼0.05), and those
with higher educational level (P¼0.000004). The global score was
negatively correlated to age (0.000006), although obviously, younger
respondents were also those still working.
No relationship was found between this mean score and the type of
cancer risk (breast/ovarian or colon), answering the second mailing,
gender, marital status, number of children or the discovery of new
cancers in the family since the last genetic consultation.
Evolution of subjects’ knowledge
The mean knowledge score did not change with increasing
delay between the date of the genetic counseling and the survey
Table 1 General characteristics of subjects (for categorical
parameters numbers and percentages are given, average±standard
deviation (range) for quantitative ones)
Items Distribution parameters
Gender
Female 291 (86.4%)
Male 46 (13.6%)
Age (at survey)
Mean 52.5±14.6 (SD)
Range (18–82)
Marital situation
Lives in couple 249 (77.6%)
Other 72 (22.4%)
Number of children 1.7±1.1 (0–5)
Educational level
Primary 61 (19.2%)
High school 137 (43.3%)
University 119 (37.5%)
Employment
Employed 168 (50.1%)
Retired 115 (34.3%)
Homemaker 14 (4.2%)
Unemployed 3 (0.9%)
Other (disabledy)3 7 ( 1 0 . 5 % )
Profession related to medicine
No 264 (84.6%)
Yes 48 (15.4%)
Time from genetic counseling 1.8 years±1.7 (0–9)
Personal mutation status
Mutated 122 (36.2%)
Not mutated 215 (63.8%)
Belongs to a mutated family
Yes 166 (49.3%)
No 171 (50.7%)
Familial cancer risk
Breast 280 (83.1%)
Colon 57 (16.9%)
Pathological history
None known 136 (40.3%)
Benign 12 (3.6%)
Cancer 189 (56.1 %)
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Figure 2 Delay between genetic counseling and the survey.
Table 2 Characteristics of responders and non-responders
No answer To 1st mailing To 2nd mailing P-valuea
Number of subjects 242 289 48
Age at survey 54.4±14.7 52.9±14.3 58.2±12.0 0.11
Males 17.7% 13.1% 16.7% 0.22
Cancer history 47.3% 56.0% 56.1% 0.11
Mutated 37.3% 36.0% 37.5% 0.94
Breast/ovarian cancer risk 78.0% 84.1% 77.1% 0.16
Number of children 1.71±1.28 1.52±1.13 1.54±1.22 0.33
Married — 77.3% 79.0% 0.80
Average delay after
consulting (years)
2.26±2.31 1.78±1.68 2.16±1.77 0.12
aThis probability corresponds to tests comparing all three means or proportions in the same time.
6.85
7.05
7.27
7.92
6.0
Type of medical
prevention
Meaning
of a hereditary
predisposition
Steps for starting
a genetic enquiry
General
information
Average score (of 10)
Scores 8.5 8.0 7.5 7.0 6.5
Figure 3 Mean scores with 95% conﬁdence intervals for main topics.
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European Journal of Human Genetics(r¼ 0.009, not signiﬁcant (NS)). The lack of correlation was
conﬁrmed for each sub-scale: the type of medical prevention
(correlation coefﬁcient r¼ 0.053, NS), the meaning of hereditary
predisposition (r¼0.056, NS), the steps to start a personal genetic
inquiry (r¼ 0.045, NS) and the general information score
(r¼ 0.011, NS). This stability did not vary among classes
of age (cut-off¼60 years), although the regression line for older
people was signiﬁcantly lower than for younger people (P¼0.0075).
Mutation carrier status did not either impact this stable trend
(P¼0.48).
The only parameter tending to inﬂuence the evolution of
knowledge was the type of cancer risk (P¼0.06 for the global score),
especially (Figure 4) for the general information subscale (P¼0.017).
Subjects with breast/ovarian hereditary risk showed a rather decreas-
ing regression line through time (r¼ 0.12, P¼0.08), while colon
cancer risk was associated to an increasing line (r¼0.22, P¼0.05). But
this difference was not due to sex, although sex was related to cancer
risk location.
Differences between speciﬁc and non-speciﬁc knowledge
Following the reviewers’ suggestions, two types of knowledge were
separately scored:
  A speciﬁc one characterizing genetic data related to the hereditary
predisposition. It comprised 15 items of the ‘general information’
subscale.
  A non-speciﬁc knowledge gathering the other nine questions that
had a more general scope.
Although these two types of information signiﬁcantly differed in
average (8.1±1.2 for the speciﬁc information versus 8.7±1.2 for the
more general one; Po10 7), no trend in time could be noticed and
thus no difference between the two slopes which were close to zero
(P¼0.51). Both knowledge types were associated to educational level
(P¼0.000002 and P¼0.0002, respectively). Concerning the non-
speciﬁc information, mutated subjects did not differ from non-
mutated ones (P¼0.11) but a slightly higher level of speciﬁc knowl-
edge characterized the mutated individuals (8.3±1.2 versus 8.0±1.1
for non-mutated ones, P¼0.018). The same analysis depending on the
type of cancer risk (breast/ovarian or colon) did not increase dis-
crepancies.
A special attention in relationship with both types of knowledge was
paid to the non-mutated group: this latter gathered two kinds of
individuals:
  The true-negatives: they were tested negative although they belong
to families where a deleterious mutation exists. They have the same
cancer risk as the general population.
  The non-informative individuals: they belong to these at-risk
families where no known mutation is discovered. Their cancer
risk is high although they cannot be sure they have inherited any
mutation.
These two groups of individuals seemed to behave differently
(Figure 5): for the true-negative persons, the level of speciﬁc
knowledge (8.1±1.2) was quite similar (P¼0.17) to the level of
their general knowledge (8.4±1.3). For non-informative persons,
both scores were not alike (Po10 6): means equaled, respectively,
7.8±1.1 and 8.8±1.1. Using the ratio speciﬁc over non-speciﬁc
knowledge, true-negatives seemed to have better understood
the speciﬁc genetic information than non-informative individuals
(P¼0.0055). The particularity of non-informative subjects was
also conﬁrmed by their lower level of speciﬁc knowledge when
compared with true-positive individuals (ie mutated): 8.3±1.2 for
these latter (P¼0.005 and P¼0.021 for the comparison of ratio), while
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European Journal of Human Geneticstheir level of non-speciﬁc knowledge did not differ (8.8±1.0 versus
8.8±1.2, P¼0.49).
DISCUSSION
This prospective survey belongs to the very few that studied the
evolution of genetic knowledge of persons with a cancer hereditary
risk. The range of topics surveyed appeared adequate to answer our
questions. The 58% response rate was rather good for a survey sent by
mail. Because of the randomization, sample should be representative
of all our patients. A second mailing to 1/3 of non-respondents
showed no response bias.
Surprisingly, the outcome did not conﬁrm our initial hypothesis:
the observed level of knowledge of persons who had undergone
genetic counseling did not change with time, although it did depend
on their age and educational level. It seems that once they had been
informed, the information was retained. The mean value of our scores
stands at 7.28 of 10, meaning 73% of the information is rather well
recalled. This tallies with Michie’s statistics10 (76%) and Somer’s
ones15 (65–86%) but diverges from DiCastro13 (30–62%) and
Bober12 (10–50%). This discrepancy may arise from the type of
knowledge investigated. Although DiCastro and Bober question
about very speciﬁc points (cancer risk, heriditary likelihood and
prevention clues), we tried to evaluate a larger panel of knowledge.
It is also possible that qualitative information may be easier to
memorize than quantitative ones. On an other hand, Bober’s mode
of questioning was very harsh: ‘Please, describe all of the recommenda-
tions you received during your visit.’T h i sk i n do fo p e nq u e s t i o nl e a v e s
the subject helpless. In contrast, a set of questions focusing on each
point will favor subjects’ recall and probably better evaluate the real
level of their knowledge, although it does not guarantee that this
knowledge will promote a correct prevention attitude on the long run.
Several reasons may explain the stability we noticed. Probands and
their relatives have other sources of information (eg media and
internet) that refresh their knowledge. Independently, intra-family
communication promotes sharing and renewal of this information.
Finally, persons at risk undergo frequent medical supervision that
gives as many occasions to learn more about their familial predis-
position.
The third point is conﬁrmed by the difference in Figure 4 observed
between breast/ovarian cancer risk and colon cancer risk. Indeed, the
colonoscopy recommended for persons at risk of colon cancer is much
more invasive than mammography and clinical examination indicated
for breast cancers, or ultrasonography and cervical smear for ovarian
cancers. This may change the global attitude of patients that have to
cope with such threats, and inﬂuence their search for information.
Considering the results in Figure 5, there may be some good reasons
to spend more counseling time with non-informative subjects, that is,
the individuals belonging to at-risk families where no known muta-
tion is found. These subjects appeared to have the lowest score of
speciﬁc knowledge, although they performed very well with the more
global information. Perhaps the uncertainty concerning their cancer
predisposition background may blur their understanding of speciﬁc
genetic mechanisms that sustain any hereditary risk.
A possible limitation of this study can be found in its design.
Subjects’ knowledge was not collected just after genetic counseling and
then again years after. Therefore no paired test could be done. Instead,
we supposed that recent consultants were representative for the level of
knowledge immediately after consultation, and older consultations for
knowledge retained over time. As no major changes have been made
in the way genetic counseling is provided to patients, this strategy
appeared pertinent. This might be discussed, as this 10-year period has
presented contextual changes, for example, with the generalization of
internet access and content. Conclusions drawn from this study may
be less precise than one assessing the same patients over time, with
individual variations remaining invisible. But this is not likely to
reverse the global tendency observed in the survey. An other weakness
of our study comes from the sampling method used: randomization,
necessary to guarantee that no selection bias would intervene in our
statistics, has prevented us from having similar population sizes in
each period of time. Thus the outcomes in older consultants may lack
of acuracy.
The overall conclusion of these results is that it does not appear
necessary to renew genetic consultations to keep patients knowledge-
able about their genetic risk: the present counseling process seems
sufﬁcient to give them the necessary information for their medical
follow-up, and for the subjects to transmit information to their
relatives. The supply of an audiotape of the consultation, a solution
tested by Watson et al,11 does not seem either to be useful as it did not
help increase the acuracy of retained knowledge. Nevertheless, the
lowest-scoring subscale in our survey was the one concerning the
medical examinations required for screening and their frequency: a
same conclusion can be drawn from Bober et al,12 as only 33–43% of
screening information were recalled. This suggests that patients need
more help to achieve compliance and perhaps the counseling team
could have a more active role in this process. Concerning the subgroup
of subjects belonging to families where no known mutation is found, a
special attention should be paid to the explanations they receive: it
seems that they are less able to understand speciﬁc genetic informa-
tion, as their familial cancer risk remains unexplained.
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